推荐产品
等級
ACS reagent
品質等級
蒸汽密度
2.49 (vs air)
蒸汽壓力
71 mmHg ( 20 °C)
化驗
≥99.0%
形狀
liquid
自燃溫度
960 °F
expl. lim.
10.1 %
雜質
≤0.0005 meq/g Titr. acid
≤0.20% water
蒸發殘留物
≤0.0025%
顏色
APHA: ≤15
折射率
n20/D 1.379 (lit.)
bp
80 °C (lit.)
mp
−87 °C (lit.)
密度
0.805 g/mL at 25 °C (lit.)
SMILES 字串
CC(CC)=O
InChI
1S/C4H8O/c1-3-4(2)5/h3H2,1-2H3
InChI 密鑰
ZWEHNKRNPOVVGH-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
一般說明
2-丁酮是一种有机化合物，在化学工业中可用作氧化反应活化剂、萃取剂、溶剂和化学中间体。它可以通过2-丁醇的催化脱氢来生产。
應用
2-丁酮可作为溶剂用于：
- 多元醇与二异氰酸酯经聚合反应合成水性聚氨酯。
- 在铝催化下氧杂环丁烷与二氧化碳化学选择性偶联合成六元环碳酸酯。
特點和優勢
- 低沸点溶剂
- 溶解能力强
- 溶解物质与粘度的比率高
- 与各种碳氢化合物混溶不影响固体′的含量或粘度
- 由于其密度低，体积/质量合适
- 蒸发速度快
訊號詞
Danger
危險聲明
危險分類
Eye Irrit. 2 - Flam. Liq. 2 - STOT SE 3
標靶器官
Central nervous system
安全危害
儲存類別代碼
3 - Flammable liquids
水污染物質分類（WGK）
WGK 1
閃點（°F）
30.2 °F - closed cup
閃點（°C）
-1 °C - closed cup
A simple one-pot multicomponent synthesis of an octahedral nanocontainer molecule.
Liu X and Warmuth R.
Nature Protocols, 2(5), 1288-1296 (2007)
C Philippe et al.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 69(9), 1212-1217 (2011-05-10)
[(11)C]PIB is still the standard PET compound for Alzheimer imaging targeting beta-amyloid plaques. We aimed to establish a fully-automated procedure for the synthesis and purification of [(11)C]PIB with a high degree of reliability and improved specific activity as well as
A volumetric and viscosity study for the mixtures of 1-n-butyl-3-methylimidazolium tetrafluoroborate ionic liquid with acetonitrile, dichloromethane, 2-butanone and N, N-dimethylformamide.
Wang J, et al.
Green Chemistry, 5(5), 618-622 (2003)
L B Goldsmith et al.
Contact dermatitis, 19(5), 348-350 (1988-11-01)
Irritant contact dermatitis along with an increased transepidermal water loss can result from exposing the skin to solvents. A study of the interaction of various solvents with human stratum corneum was made using thin-layer chromatography. Comparison of 10 solvents (trichloroethylene
Consalvo Petti et al.
Oncotarget, 6(1), 221-233 (2014-12-05)
Constitutively active receptor tyrosine kinases (RTKs) are known oncogenic drivers and provide valuable therapeutic targets in many cancer types. However, clinical efficacy of RTK inhibitors is limited by intrinsic and acquired resistance. To identify genes conferring resistance to inhibition of
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门